易炜 广州医科大学附属第一医院放疗科副主任医师中山大学医学博士主要研究方向为鼻咽癌及直肠癌的放射生物学行为及转移的分子机制，主持广东省自然科学基金项目。广东省医学会放射肿瘤学分会第六届委员会青年委员广东省医学会肿瘤学分会鼻咽癌学组委员广东省医师协会放射治疗医师分会第一届委员会神经肿瘤专业组委员广州市抗癌协会放射肿瘤专业委员会委员《中华临床医师杂志》（电子版）杂志特约编辑近年发表的代表性论文[1] Wei Yi, Jiani Wang, Zhicheng Yao, Qinglei Kong, Nana Zhang, Wei Mo, Lihua Xu1, Xian Li. The expression status of ZIC2 as a prognostic marker for nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2018;11(9):4446-4460.[2] Chang H, Yi W, Wang X, Tao Y, Yang X, Chen C, Zhang W, Zhou S, Liu S, Li X, Ding S, Li J, Li G, Shao X, Liu Y, Song W, Xia Y. Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial, Chin J Cancer Res. 2018 6;30(3):307-314.[3] Yi Wei，Zhi-Gang Liu，Xian Li，Jiao Tang，Chang-Bin Jiang，Jing-Ye Hu，Zi-Wei Tu，Hui Wang，Dao-Li Niu，Yun-Fei Xia. CT diagnosed severe skull base bone destruction predicts bone distant metastasis in early N stage nasopharyngeal carcinoma, OncoTargets and Therapy, 2016, 9: 7011-7017.[4] Hu JY, Yi Wei, Wei X, Zhang MY, Xu R, Zeng LS, Huang ZJ, Chen JS. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer, Biomed Pharmacother, 2016, 79: 247-253. (IF: 2.759)[5] Yi Wei, Li X, Liu Z, Jiang C, Niu D, Xia Y. A risk score model for the metastasis of level Ib lymph node based on the clinicopathological features of nasopharyngeal carcinoma in a large sample. Mol Clin Oncol. 2014. 2(5): 789-797.

鼻咽癌、上颌窦癌、喉癌、肺癌、肠癌的放射治疗。